Several speakers started by showing tables listing ongoing immunotherapies that have sprung up since their first demonstration in mice (Schenk et al., 1999). ???There is a huge amount of activity on immunotherapy going on in industry,??? said Dale Schenk of Elan and Janssen Alzheimer Immunotherapy.